liraglutide semaglutide vs. liraglutide: Head-to-head study reveals a diabetes risk difference GLP-1 Drug Impurities & Degradation

New clinical trials and results would allow Eli Lilly to complete its submission to the FDA for a potential approval by the end of the year

Modified Gold Nanoparticles to Overcome the Chemoresistance to Gemcitabine in Mutant p53 Cancer Cells

Ashok Mehta on Substack for long-form writing on Semaglutide, Tirzepatide, nutrigenomics, and the science behind physician-supervised weight loss free, straight from your physician

This dual verification gives extra confidence in product quality and experimental reproducibility

In this work, we systematically evaluate the therapeutic efficacy and AEs of GLP-1 RAs across multiple disease areas through an umbrella review of meta-analyses